Nociceptive thermal threshold testing in horses - effect of neuroleptic sedation and neuroleptanalgesia at different stimulation sites.
Authors: Poller Christin, Hopster Klaus, Rohn Karl, Kästner Sabine B R
Journal: BMC veterinary research
Summary
# Editorial Summary: Thermal Nociception Testing in Sedated Horses Understanding how sedatives and analgesics affect pain perception in horses is crucial for both clinical assessment and research methodology, yet few studies have systematically examined this relationship across different body sites and time points. Researchers compared thermal nociceptive thresholds in eleven horses using a randomised cross-over design, testing three treatments—saline control, acepromazine alone (0.05 mg/kg IV), and acepromazine combined with buprenorphine (0.0075 mg/kg IV)—with heat stimulation applied to either the nostrils or withers at ten intervals over nine hours. Acepromazine increased thermal thresholds (indicating reduced pain perception) significantly at the nostril site but produced minimal change at the withers, whilst the addition of buprenorphine did not substantially enhance this effect, suggesting site-specific influences on nociceptive response and incomplete analgesia from the opioid at the tested dose. For practitioners using thermal threshold testing as a diagnostic tool or researchers employing it in pain studies, these findings highlight that sedation type, anatomical location and timing post-administration substantially alter results, making standardisation essential; the nostril's apparent sensitivity to acepromazine also raises questions about whether this site is optimal for objective nociceptive assessment in clinical horses.
Read the full abstract on PubMed
Practical Takeaways
- •Acepromazine with buprenorphine provides superior analgesia compared to acepromazine alone for thermal pain management in horses
- •Stimulation site matters when assessing pain response — withers showed greater drug effect than nostrils, suggesting regional variation in nociception
- •Analgesic effects are time-dependent; peak efficacy occurs within 15-165 minutes, so procedures should be timed accordingly
Key Findings
- •Acepromazine alone and acepromazine with buprenorphine both significantly elevated thermal thresholds compared to saline control
- •Neuroleptanalgesia (acepromazine + buprenorphine) produced higher thermal thresholds than neuroleptic sedation (acepromazine alone) at withers stimulation sites
- •Thermal threshold effects varied by stimulation site, with different response patterns at nostrils versus withers
- •Effects peaked between 15-165 minutes post-treatment with return toward baseline by 525 minutes